Israeli drug company developing a non-stimulant ADHD treatment.
Industry: Health Care
First Day Return: -5.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/14/2013 |
Offer Price | $8.00 |
Price Range $10.00 - $12.00 | |
Offer Shares (mm) | 3.1 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/21/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Tel Aviv, Israel |
Founded | 2008 |
Employees at IPO | 3 |
Website www.alcobra-pharma.com |